Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice ; day:14 ; month:11 ; year:2024 ; pages:1-10
Hepatology international ; (14.11.2024), 1-10
- Creator
-
Terashima, Takeshi
Yamashita, Tatsuya
Arai, Kuniaki
Takata, Noboru
Hayashi, Tomoyuki
Seki, Akihiro
Nakagawa, Hidetoshi
Nio, Kouki
Iida, Noriho
Yamada, Shinya
Shimakami, Tetsuro
Takatori, Hajime
Tsuji, Kunihiro
Sunagozaka, Hajime
Mizukoshi, Eishiro
Honda, Masao
Takeuchi, Shinji
Yamashita, Taro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12072-024-10741-y
- URN
-
urn:nbn:de:101:1-2502040928334.097382041448
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Terashima, Takeshi
- Yamashita, Tatsuya
- Arai, Kuniaki
- Takata, Noboru
- Hayashi, Tomoyuki
- Seki, Akihiro
- Nakagawa, Hidetoshi
- Nio, Kouki
- Iida, Noriho
- Yamada, Shinya
- Shimakami, Tetsuro
- Takatori, Hajime
- Tsuji, Kunihiro
- Sunagozaka, Hajime
- Mizukoshi, Eishiro
- Honda, Masao
- Takeuchi, Shinji
- Yamashita, Taro
- SpringerLink (Online service)
Other Objects (12)
Comprehensive genomic profiling
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue
Comprehensive Germline Genomic Profiling of Patients with Ovarian Cancer: A Cross-Sectional Study
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice
Genomic alteration discordance in the paired primary-recurrent ovarian cancers: based on the comprehensive genomic profiling (CGP) analysis
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
Comprehensive genomic profiling
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue
Comprehensive Germline Genomic Profiling of Patients with Ovarian Cancer: A Cross-Sectional Study
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice
Genomic alteration discordance in the paired primary-recurrent ovarian cancers: based on the comprehensive genomic profiling (CGP) analysis
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
Comprehensive genomic profiling
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue
Comprehensive Germline Genomic Profiling of Patients with Ovarian Cancer: A Cross-Sectional Study
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice
Genomic alteration discordance in the paired primary-recurrent ovarian cancers: based on the comprehensive genomic profiling (CGP) analysis